Article
MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Jul 2020
Strickland Samantha L, Reddy Joseph S, Allen Mariet, N'songo Aurelie, Burgess Jeremy D, Corda Morgane M, Ballard Travis, Wang Xue, Carrasquillo Minerva M, Biernacka Joanna M, Jenkins Gregory D, Mukherjee Shubhabrata, Boehme Kevin, Crane Paul, Kauwe John S, Ertekin-Taner Nilüfer
Abstract excerpt
INTRODUCTION: MAPT H1 haplotype is implicated as a risk factor for neurodegenerative diseases including Alzheimer's disease (AD). METHODS: Using Alzheimer's Disease Genetics Consortium (ADGC) genome-wide association study (GWAS) data (n = 18,841), we conducted a MAPT H1/H2 haplotype-stratified association to discover MAPT haplotype-specific AD risk loci. RESULTS: We identified 11 loci-5 in H2-non-carriers and 6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
